What non-statistitians need to know about statistics
Stephen Senn, Prof Statistics, Univ of Glasgow, Willi Maurer, Global Head Statistical Methodology, Novartis
Stephen Senn, Prof Statistics, Univ of Glasgow,
Willi Maurer, Global Head Statistical Methodology, Novartis
If you really feel uncomfortable around statistics, Senn and Maurer made this session more understandable and enjoyable. The audience laughed a lot, this is most likely the secret to Prof Senn's success with students. The presenters discussed how statistics or biostatistics has changed in the world of clinical R&D to a position of becoming an integral player in R&D.
Also discussed was the use of Bayesian statistics especially as new tools in analysis methods to support innovative and dynamic trial design. Both speakers discussed how dynamic a tool Bayesian statistics can be, and how effectively it can be used in the conclusion section when making a decision about a drug. Prof Senn's book, Dicing with Death, is a great way to get more expertise on the subject and laugh at the same time.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Zerlasiran Achieves Significant Sustained Reduction in Lipoprotein(a) Levels with Infrequent Dosing
November 20th 2024Zerlasiran, a novel siRNA therapy, demonstrated over 80% sustained reductions in lipoprotein(a) levels with infrequent dosing in the Phase II ALPACAR-360 trial, highlighting its potential as a safe and effective treatment for patients at high risk of cardiovascular disease.
